TB CARE II core

XDR-TB Treatment: Tumpa's Story

Location

Chittagong
Bangladesh
BD

Tumpa, a 14 year old high school student, was diagnosed with TB on March 27, 2011. Although she started taking TB medication the day after, she experienced treatment failure after three months of treatment and was diagnosed with Multi Drug Resistance Tuberculosis (MDR-TB). With her new diagnosis, Tumpa started to take her medication for MDR-TB in August of that year. However, after completing 16 months of treatment, her sputum culture and follow up result remained positive. She was then diagnosed with extensively drug-resistant TB (XDR-TB) in November 2012.

News Source: 
A N M Al Imran, University Research Co., LLC
Country Program: 

Ethics of TB Prevention, Care and Control: An Assessment Tool for National Tuberculosis Programmes

Undefined

In 2010, the World Health Organisation (WHO) released Guidance on Ethics of Tuberculosis Prevention, Care and Control.  This guidance is meant to address all dilemmas related to the rights of TB patients, the community, TB programmes, and health care workers in the management of TB patients. 

The purpose of this tool is for programmes to assess themselves on topics covered in the WHO guidelines.  The tool will assist programmes in identifying potential strengths and gaps in the ethical treatment of TB patients.

Ethics of TB Prevention, Care and Control: An Assessment Tool for National Tuberculosis Programmes

Undefined

In 2010, the World Health Organisation (WHO) released Guidance on Ethics of Tuberculosis Prevention, Care and Control.  This guidance is meant to address all dilemmas related to the rights of TB patients, the community, TB programmes, and health care workers in the management of TB patients. 

The purpose of this tool is for programmes to assess themselves on topics covered in the WHO guidelines.  The tool will assist programmes in identifying potential strengths and gaps in the ethical treatment of TB patients.

TB CARE II Hosts Insurance Meeting in Bangkok

Undefined

The global drive for universal health coverage (UHC) provides important opportunities for strengthening TB control by emphasizing the need for more sustainable and effective funding models and the promotion of policies designed to improve universal access to high quality diagnosis, care and treatment.  In many countries, efforts to achieve UHC have taken the form of newly designed or expanded national and/or social health insurance programs.

TB CARE II DR TB Training Course Highlighted by CDC

Undefined

In July 2014, CDC’s Find TB Resources named Adherence to MDR-TB Treatment: The 5 A’s of Patient Support, an online course developed by the DR-TB Training Network, as its Highlight of the Month (http://findtbresources.cdc.gov/newsletter/newsletter14July.html).  This online course discusses key principles and steps to facilitate treatment adherence for patients with MDR-TB. The five A's presented in the course are: assess, advise, agree, arrange, and assist.

TB CARE II Hosts Insurance Workshop in Thailand

Undefined

The TB CARE II Project organized a workshop entitled Exploring the promise of improving access and delivery of TB services through insurance-based financing reforms in Bangkok, Thailand from September 18 -20, 2014.  The workshop provided a forum for information sharing and review of current systems for ensuring access to, and provision of, essential TB services and core public health functions in the context of universal health coverage financing reforms in Asian countries.

Pages